nova specialty pharmacy tirzepatide FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now nova specialty pharmacy tirzepatide Novera

To everyone welcoming the New Year, may 2026 be an even greater and more prosperous year for us all

But we dont yet have the robust human trials that would allow us to say this is established mainstream medicine. That distinction matters

7 The ADA continues to recommend metformin in conjunction with lifestyle interventions as first-line therapy in patients with T2D

At Shed, we spend a lot of time thinking about how to make things simpler: clearer options, more personalized care, and tools catered to women

Its especially common in people whove spent years cycling through diets or managing emotional eating patterns

A Hong Kong-based pharmaceutical company, Ascletis, is also investigating the benefit of once-daily oral drug, called ASC30, for weight loss